BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28002459)

  • 1. Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.
    Marano F; Rinella L; Argenziano M; Cavalli R; Sassi F; D'Amelio P; Battaglia A; Gontero P; Bosco O; Peluso R; Fortunati N; Frairia R; Catalano MG
    PLoS One; 2016; 11(12):e0168553. PubMed ID: 28002459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin-Loaded Nanobubbles Combined with Extracorporeal Shock Waves: Basis for a New Drug Delivery Tool in Anaplastic Thyroid Cancer.
    Marano F; Argenziano M; Frairia R; Adamini A; Bosco O; Rinella L; Fortunati N; Cavalli R; Catalano MG
    Thyroid; 2016 May; 26(5):705-16. PubMed ID: 26906083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells.
    Mayer MJ; Klotz LH; Venkateswaran V
    Anticancer Res; 2017 Dec; 37(12):6601-6607. PubMed ID: 29187435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.
    Park HS; Hong SK; Oh MM; Yoon CY; Jeong SJ; Byun SS; Cheon J; Lee SE; Moon du G
    Anticancer Res; 2014 Jul; 34(7):3457-68. PubMed ID: 24982354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High energy shock waves (HESW) enhance paclitaxel cytotoxicity in MCF-7 cells.
    Frairia R; Catalano MG; Fortunati N; Fazzari A; Raineri M; Berta L
    Breast Cancer Res Treat; 2003 Sep; 81(1):11-9. PubMed ID: 14531493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
    Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
    Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
    Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
    Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
    Springate CM; Jackson JK; Gleave ME; Burt HM
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer.
    Zhu S; Oremo JA; Li S; Zhen M; Tang Y; Du Y
    PLoS One; 2014; 9(3):e91817. PubMed ID: 24632829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Drug-Loaded Nanobubbles and Extracorporeal Shock Waves for Difficult-to-Treat Cancers.
    Cavalli R; Marano F; Argenziano M; Varese A; Frairia R; Catalano MG
    Curr Drug Deliv; 2018; 15(6):752-754. PubMed ID: 29046151
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
    Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
    J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model.
    Marano F; Frairia R; Rinella L; Argenziano M; Bussolati B; Grange C; Mastrocola R; Castellano I; Berta L; Cavalli R; Catalano MG
    Endocr Relat Cancer; 2017 Jun; 24(6):275-286. PubMed ID: 28487350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
    Martin SK; Kyprianou N
    Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating tumor reactive stroma by extracorporeal shock waves to control prostate cancer progression.
    Rinella L; Pizzo B; Frairia R; Delsedime L; Calleris G; Gontero P; Zunino V; Fortunati N; Arvat E; Catalano MG
    Prostate; 2020 Sep; 80(13):1087-1096. PubMed ID: 32609927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
    Luo Y; Ling Y; Guo W; Pang J; Liu W; Fang Y; Wen X; Wei K; Gao X
    J Control Release; 2010 Oct; 147(2):278-88. PubMed ID: 20655966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells.
    Catalano MG; Costantino L; Fortunati N; Bosco O; Pugliese M; Boccuzzi G; Berta L; Frairia R
    Thyroid; 2007 Feb; 17(2):91-9. PubMed ID: 17316109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer.
    Başpınar Y; Erel-Akbaba G; Kotmakçı M; Akbaba H
    Int J Pharm; 2019 Jul; 566():149-156. PubMed ID: 31129344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro.
    Skvortsova I; Skvortsov S; Haidenberger A; Devries A; Nevinny-Stickel M; Saurer M; Lukas P; Seppi T
    J Chemother; 2004 Aug; 16(4):372-80. PubMed ID: 15332713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.